50 related articles for article (PubMed ID: 8823806)
21. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y
Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696
[TBL] [Abstract][Full Text] [Related]
23. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
[TBL] [Abstract][Full Text] [Related]
24. Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene.
Asano T; An T; Mayes J; Zwelling LA; Kleinerman ES
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):307-13. PubMed ID: 8870683
[TBL] [Abstract][Full Text] [Related]
25. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
26. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
27. [Antitumor agents targeting mammalian topoisomerases].
Nakano H
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1550-5. PubMed ID: 1651681
[TBL] [Abstract][Full Text] [Related]
28. DNA topoisomerase II mutations and resistance to anti-tumor drugs.
Vassetzky YS; Alghisi GC; Gasser SM
Bioessays; 1995 Sep; 17(9):767-74. PubMed ID: 8763829
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Beck WT; Danks MK
Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
[TBL] [Abstract][Full Text] [Related]
30. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
Furukawa M; Harada T; Tanaka T; Kuwano M
Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of resistance to DNA topoisomerase II inhibitors].
Kohno K; Takano H; Kuwano M
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1568-73. PubMed ID: 1651684
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?
Di Leo A; Isola J
Clin Breast Cancer; 2003 Aug; 4(3):179-86. PubMed ID: 14499010
[TBL] [Abstract][Full Text] [Related]
33. DNA topoisomerase I and II as targets for rational design of new anticancer drugs.
Cummings J; Smyth JF
Ann Oncol; 1993 Aug; 4(7):533-43. PubMed ID: 8395870
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.
Jensen PB; Sehested M
Biochem Pharmacol; 1997 Oct; 54(7):755-9. PubMed ID: 9353129
[TBL] [Abstract][Full Text] [Related]
35. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
36. [Topo II alpha in breast cancer: an update].
Wei J; Liu FF; Fu L
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):132-5. PubMed ID: 18681328
[No Abstract] [Full Text] [Related]
37. [Pleiotropic resistance associated with topoisomerases].
Riou JF; Pommier Y
Bull Cancer; 1994 Dec; 81 Suppl 2():62s-68s. PubMed ID: 7727861
[TBL] [Abstract][Full Text] [Related]
38. Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.
Lee JH; Berger JM
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671531
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]